New Zealand markets open in 7 hours 15 minutes

Novo Nordisk A/S (NVO)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
104.61+2.06 (+2.01%)
As of 09:45AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 227.34B
Enterprise value 226.60B
Trailing P/E 34.54
Forward P/E 25.91
PEG ratio (5-yr expected) 1.73
Price/sales (ttm)11.11
Price/book (mrq)23.17
Enterprise value/revenue 1.44
Enterprise value/EBITDA 3.07

Trading information

Stock price history

Beta (5Y monthly) 0.29
52-week change 35.26%
S&P500 52-week change 3-15.36%
52-week high 3122.16
52-week low 391.51
50-day moving average 3105.65
200-day moving average 3107.07

Share statistics

Avg vol (3-month) 31.68M
Avg vol (10-day) 31.43M
Shares outstanding 52.26B
Implied shares outstanding 6N/A
Float 81.62B
% held by insiders 10.01%
% held by institutions 18.67%
Shares short (14 Sept 2022) 43.12M
Short ratio (14 Sept 2022) 41.65
Short % of float (14 Sept 2022) 4N/A
Short % of shares outstanding (14 Sept 2022) 40.14%
Shares short (prior month 14 Aug 2022) 42.31M

Dividends & splits

Forward annual dividend rate 41.6
Forward annual dividend yield 41.61%
Trailing annual dividend rate 311.15
Trailing annual dividend yield 310.87%
5-year average dividend yield 42.06
Payout ratio 446.51%
Dividend date 322 Aug 2022
Ex-dividend date 411 Aug 2022
Last split factor 25:1
Last split date 308 Jan 2014

Financial highlights

Currency in DKK.

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022


Profit margin 32.14%
Operating margin (ttm)42.68%

Management effectiveness

Return on assets (ttm)22.25%
Return on equity (ttm)72.19%

Income statement

Revenue (ttm)157.25B
Revenue per share (ttm)68.97
Quarterly revenue growth (yoy)24.90%
Gross profit (ttm)117.14B
Net income avi to common (ttm)50.54B
Diluted EPS (ttm)2.88
Quarterly earnings growth (yoy)9.90%

Balance sheet

Total cash (mrq)31.04B
Total cash per share (mrq)13.68
Total debt (mrq)25.43B
Total debt/equity (mrq)34.16
Current ratio (mrq)0.94
Book value per share (mrq)32.81

Cash flow statement

Operating cash flow (ttm)66.04B
Levered free cash flow (ttm)55.34B